GlassScriptPhysician profile
Manish K Gupta
NPI 1770687386
$74,802.91
in general payments reported to CMS, 2019-2025
31 companies · $18K in 2025
The $18K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $983 · 2021: $8,750 · 2022: $526 · 2023: $3,412 · 2024: $13K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Food and Beverage: $5,005 · Travel and Lodging: $2,326 · Education: $41.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,900.00 |
| Food and Beverage | $5,005.15 |
| Travel and Lodging | $2,325.95 |
| Education | $41.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $45,507.21 | 2019-2025 | Real Intelligence, Ri Hip Navigation, Or3o Dual Mobility |
| Bone Support INC. | $25,720.40 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Stryker Corporation | $1,054.09 | 2019-2025 | Mako, Hoffmann, Gamma |
| Encore Medical, LP | $509.65 | 2019-2020 | |
| Carbofix Orthopedics INC | $281.33 | 2019-2022 | |
| Djo, LLC | $229.89 | 2019-2023 | Cmf |
| Vericel Corporation | $206.81 | 2021-2025 | Maci |
| Southern Edge Orthopaedics, INC. | $164.82 | 2023 | |
| Dynasplint Systems INC. | $134.99 | 2021 | |
| Anika Therapeutics, INC. | $113.36 | 2025 | Integrity Implant |
| Medical Device Business Services, INC. | $106.73 | 2025 | Velys |
| Kyocera Medical Technologies, INC. | $96.16 | 2025 | |
| W. L. Gore & Associates, INC. | $94.24 | 2019 | |
| Curonix LLC | $90.68 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biocomposites INC | $82.87 | 2025 | Stimulan |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $73.79 | 2024 | |
| Catalyst Orthoscience | $66.40 | 2024 | Catalyst Csr Shoulder System |
| Royal Biologics, INC. | $65.72 | 2025 | |
| Zimmer Biomet Holdings, INC. | $38.51 | 2025 | Rosa |
| Trice Medical, INC. | $27.01 | 2024 | |
| Wright Medical Technology, INC. | $25.77 | 2019 | |
| Kci USA, INC. | $24.00 | 2023 | Prevena |
| Orthalign INC | $23.50 | 2025 | Orthalign Plus |
| Pacira Therapeutics, INC. | $23.48 | 2021 | |
| Astellas Pharma US INC | $17.69 | 2023 | Lexiscan |
| Depuy Synthes Sales INC. | $16.24 | 2021 | |
| Romark Laboratories, Lc | $7.57 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.